Viktoria Thurfjell
PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research Carina Strell
- E-mail:
- viktoria.thurfjell@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Specialist physician at Department of Immunology, Genetics and Pathology; Clinical units; Clinical pathology
- E-mail:
- viktoria.thurfjell@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
75185 Uppsala - Postal address:
- Rudbecklaboratoriet
75185 Uppsala
Publications
Recent publications
Part of Breast Cancer Research and Treatment, p. 499-509, 2025
- DOI for Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
- Download full text (pdf) of Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
Part of The Breast, 2025
- DOI for Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Download full text (pdf) of Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Part of Archives of Pathology & Laboratory Medicine, 2024
- DOI for Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
- Download full text (pdf) of Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Part of Translational Lung Cancer Research, p. 2477-2494, 2022
- DOI for Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
- Download full text (pdf) of Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
Part of European Journal of Cancer, p. 128-137, 2022
- DOI for Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
- Download full text (pdf) of Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
All publications
Articles in journal
Part of Breast Cancer Research and Treatment, p. 499-509, 2025
- DOI for Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
- Download full text (pdf) of Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial
Part of The Breast, 2025
- DOI for Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
- Download full text (pdf) of Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting
Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Part of Archives of Pathology & Laboratory Medicine, 2024
- DOI for Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
- Download full text (pdf) of Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Part of Translational Lung Cancer Research, p. 2477-2494, 2022
- DOI for Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
- Download full text (pdf) of Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
Part of European Journal of Cancer, p. 128-137, 2022
- DOI for Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
- Download full text (pdf) of Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
Part of Cancer Immunology and Immunotherapy, p. 2577-2587, 2021
- DOI for PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
- Download full text (pdf) of PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
Part of Clinical Cancer Research, p. 3469-3477, 2021